Trial
NCT03590574
Phase I/II Study Evaluating AUTO4 in Patients With T Cell Receptor Beta Constant (TRBC)1 Positive T Cell Lymphoma
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Autolus Limited
Collaborators
—
Condition
T Cell Non-Hodgkin Lymphoma
Intervention
AUTO4
Why stopped
Only Phase I of the study was conducted.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-03-16